Jump to navigation
LESSONS must be learnt from the regulatory history of Fluvax to ensure the long-term success of paediatric influenza vaccination programs, experts insist.
If you have an account select Login. If you are new to Medical Observer select Join.
Neil Bramwell is a regular feature writer and contributor for MO.
More articles by this author >
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.